Skip to search formSkip to main contentSkip to account menu

pervanadate

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Abstract HER2/neu, a M r 185,000 tyrosine kinase receptor that is overexpressedin breast cancer, undergoes proteolytic cleavage… 
2009
2009
1 Complete Title: Protein Tyrosine Kinase Involvement in Learning-Produced Changes in 2 Hermissenda Type B Photoreceptors 3 4… 
2009
2009
Cell acítvation via plasma membrane receptors can be divided in two types: (A) G-protein-linked serpentines and (B) tyrosine… 
2007
2007
Objective To study the effects of pervanadate(Per),the inhibitor of protein tyrosine phosphotases on the alterations of… 
2006
2006
OBJECTIVE:To study the effects of pervanadate (Per) on the changes of growth-responsiveness in BET-2 cells induced by 60Co γ-ray… 
2006
2006
Objective To study the effects of Pervanadate(Per) on BET-2 cells cell cycle arrest and apoptosis induced by ionizing radiation… 
2004
2004
To comprehend the feasibility of the inhibitor of tyrosine phosphatase pervanadate using for therapy of radiation injury and… 
1999
1999
HER2/neu, a Mr 185,000 tyrosine kinase receptor that is overexpressed in breast cancer, undergoes proteolytic cleavage of its… 
1997
1997
Metavanadate, orthovanadate, and pervanadate all inhibited [3H]QNB antagonist binding to the human brain muscarinic acetylcholine… 
1996
1996
Addition of GTPgammaS to saponin-permeabilised human neutrophils activated both the NADPH oxidase and phospholipase D (PLD). This…